Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
 
  
   
Insider Information:   Turner Heather D
Relationship:   EVP, General Counsel &...
City:   San Diego
State:   CA
   
Insider Summary:
  
   
Companies Owned :   3    
Direct Shares   88,744    

Indirect Shares

  0      
Direct Value   $58,038    

Indirect Value

  $0      
Total Shares   88,744      
Total Value   $58,038      


Atara Biotherapeutics, Inc.
 $47,951 Sangamo Biosciences Inc
 $10,087 Atara Biotherapeutics, Inc.
 $47,951 Sangamo Biosciences Inc
 $10,087
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :

    0   
    0    

     Stock price went up :

    0   
    0    
     Stock price went down :
    0   
    0    
   
     Gain/Loss Ratio :
   0.0   
   0.0   
     Percentage Gain/Loss :
     0.0%
   0.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Orexigen Therapeutics, Inc. OREX SVP, Gen. Counsel & Se... 2014-12-02 0 2012-07-17 0    Premium*  
            Atara Biotherapeutics, Inc. ATRA Former EVP, GC & Sec. 2018-02-09 69,494 2016-02-09 0    Premium*  
            Sangamo Biosciences Inc SGMO EVP, General Counsel &... 2019-02-25 19,250 2019-02-25 0    Premium*  
* Premium Members only  

Records found :    17         Free Registration Required For Full Results.    Limit: 25

Download
  Page 1 of 1
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

 
3m +/-  
Form
SGMO Sangamo Biosciences Inc EVP, General Counsel & Sec.   •       –      –    2019-02-25 4 A $0.00 $0 D/D 19,250 19,250 0 -
ATRA Atara Biotherapeutics, In... Former EVP, GC & Sec.   •       –      –    2018-02-09 4 AS $36.63 $464,210 D/D (12,214) 69,494 0 -
ATRA Atara Biotherapeutics, In... EVP, General Counsel & Sec.   •       –      –    2018-02-06 4 D $35.80 $158,737 D/D (4,434) 81,708 0 -
ATRA Atara Biotherapeutics, In... EVP, General Counsel & Sec.   •       –      –    2017-02-09 4 AS $15.70 $192,067 D/D (12,215) 86,142 0 -
ATRA Atara Biotherapeutics, In... EVP, General Counsel & Sec.   •       –      –    2017-02-06 4 A $0.00 $0 D/D 49,500 98,357 0 -
ATRA Atara Biotherapeutics, In... VP, General Counsel & Sec.   •       –      –    2016-02-09 4 A $0.00 $0 D/D 48,857 48,857 0 -
OREX Orexigen Therapeutics, In... SVP, Gen. Counsel & Secretary   •       –      –    2014-12-02 4 AS $6.00 $135,858 D/D (22,643) 0 0 -
OREX Orexigen Therapeutics, In... SVP, Gen. Counsel & Secretary   •       –      –    2014-12-02 4 OE $1.66 $37,587 D/D 22,643 22,643 0 -
OREX Orexigen Therapeutics, In... SVP, Gen. Counsel & Secretary   •       –      –    2014-11-25 4 AS $6.00 $44,292 D/D (7,382) 0 0 -
OREX Orexigen Therapeutics, In... SVP, Gen. Counsel & Secretary   •       –      –    2014-11-25 4 OE $1.66 $12,254 D/D 7,382 7,382 0 -
OREX Orexigen Therapeutics, In... SVP, Gen. Counsel & Secretary   •       –      –    2014-11-24 4 AS $5.77 $138,587 D/D (24,006) 0 0 -
OREX Orexigen Therapeutics, In... SVP, Gen. Counsel & Secretary   •       –      –    2014-11-24 4 OE $1.66 $39,850 D/D 24,006 24,006 0 -
OREX Orexigen Therapeutics, In... VP, Gen. Counsel & Secretary   •       –      –    2014-09-22 4 S $4.47 $1,339,500 D/D (300,000) 0 0 -
OREX Orexigen Therapeutics, In... VP, Gen. Counsel & Secretary   •       –      –    2014-09-22 4 OE $1.66 $498,000 D/D 300,000 300,000 0 -
OREX Orexigen Therapeutics, In... VP, Gen. Counsel & Secretary   •       –      –    2013-11-29 4 A $5.34 $21,253 D/D 3,980 3,980 0 -
OREX Orexigen Therapeutics, In... SVP, Gen. Counsel & Secretary   •       –      –    2012-07-17 4 AS $7.68 $633,448 D/D (82,433) 0 0 -
OREX Orexigen Therapeutics, In... SVP, Gen. Counsel & Secretary   •       –      –    2012-07-17 4 OE $1.66 $136,839 D/D 82,433 82,433 0 -

  17  Records found
  1     
  Page 1 of 1  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed